Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells

Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells

We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus cytokine-induced killer cells.

Bibliographic Details
Main Authors: Zhenzhen eHui, Xinwei eZhang, Baozhu eRen, Runmei eLi, Xiubao eRen
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-12-01
Series:Frontiers in Immunology
Subjects:
Cytokine-Induced Killer Cells
Immunotherapy
Thrombocytopenia
Non-small cell lung cancer
Pembrolizumab
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00633/full
id doaj-a7e480975fbd4d7e9ed617003f746549
record_format Article
spelling doaj-a7e480975fbd4d7e9ed617003f7465492020-11-24T23:12:24ZengFrontiers Media S.A.Frontiers in Immunology1664-32242015-12-01610.3389/fimmu.2015.00633172934Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cellsZhenzhen eHui0Xinwei eZhang1Baozhu eRen2Runmei eLi3Xiubao eRen4Tianjin Medical University Cancer Institute and HospitalTianjin Medical University Cancer Institute and HospitalTianjin Medical University Cancer Institute and HospitalTianjin Medical University Cancer Institute and HospitalTianjin Medical University Cancer Institute and HospitalWe present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus cytokine-induced killer cells.http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00633/fullCytokine-Induced Killer CellsImmunotherapyThrombocytopeniaNon-small cell lung cancerPembrolizumab
collection DOAJ
language English
format Article
sources DOAJ
author Zhenzhen eHui
Xinwei eZhang
Baozhu eRen
Runmei eLi
Xiubao eRen
spellingShingle Zhenzhen eHui
Xinwei eZhang
Baozhu eRen
Runmei eLi
Xiubao eRen
Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells
Frontiers in Immunology
Cytokine-Induced Killer Cells
Immunotherapy
Thrombocytopenia
Non-small cell lung cancer
Pembrolizumab
author_facet Zhenzhen eHui
Xinwei eZhang
Baozhu eRen
Runmei eLi
Xiubao eRen
author_sort Zhenzhen eHui
title Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells
title_short Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells
title_full Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells
title_fullStr Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells
title_full_unstemmed Rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells
title_sort rapid response of advanced squamous non-small cell lung cancer with thrombocytopenia after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2015-12-01
description We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus cytokine-induced killer cells.
topic Cytokine-Induced Killer Cells
Immunotherapy
Thrombocytopenia
Non-small cell lung cancer
Pembrolizumab
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00633/full
work_keys_str_mv AT zhenzhenehui rapidresponseofadvancedsquamousnonsmallcelllungcancerwiththrombocytopeniaafterfirstlinetreatmentwithpembrolizumabplusautologouscytokineinducedkillercells
AT xinweiezhang rapidresponseofadvancedsquamousnonsmallcelllungcancerwiththrombocytopeniaafterfirstlinetreatmentwithpembrolizumabplusautologouscytokineinducedkillercells
AT baozhueren rapidresponseofadvancedsquamousnonsmallcelllungcancerwiththrombocytopeniaafterfirstlinetreatmentwithpembrolizumabplusautologouscytokineinducedkillercells
AT runmeieli rapidresponseofadvancedsquamousnonsmallcelllungcancerwiththrombocytopeniaafterfirstlinetreatmentwithpembrolizumabplusautologouscytokineinducedkillercells
AT xiubaoeren rapidresponseofadvancedsquamousnonsmallcelllungcancerwiththrombocytopeniaafterfirstlinetreatmentwithpembrolizumabplusautologouscytokineinducedkillercells
_version_ 1725600938512613376

Similar Items